August 6, 2024: Discovery Process Defined in Trulicity Lawsuit by Judge Marston A 19-page order was recently issued by Judge Marston covering how discovery will proceed in the Trulicity Lawsuit
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have recently gained attention for treating multiple medical conditions, including potential to treat IIH
These plans focus on protein-dense, nutrient-rich meals that are easy to digest, enjoyable to eat, and designed to support healing, without contributing to unwanted weight gain
What the AI Study Found The UPenn research team, led by senior author Sharath Chandra Guntuku of UPenn Engineering and co-author Jena Shaw Tronieri of UPenn's Center for Weight and Eating Disorders, used large language models to map patient-reported social media posts onto standardized medical terminology
But if you are taking a glucagon-like peptide-1 drug better known as GLP-1 for weight loss, the protocol for getting back on track may be different from missing a dose of antibiotics
Disclaimer: Links may contain affiliate links, which means we may get paid a commission at no additional cost to you if you purchase through this page
